SubscribeAttendees to learn how regulatory requirements are influenced by medical practice and Japanese culture.
HORSHAM, Pa., September X, 2005 – The Drug Information Association (DIA) will host a two-day workshop on Japan pharmaceutical development from November 2-3 at the Park Hyatt Philadelphia Hotel in Philadelphia.
The workshop, titled Japan Pharmaceutical Development: Regulatory Perspectives to Meet Simultaneous Global Drug Development, will highlight the key issues surrounding the drug development process in Japan and how changes in the Japanese regulatory environment affect other regions. Intended to open dialogue between regulatory authorities and pharmaceutical companies, the workshop will feature informative presentations as well as interactive panel discussions.
The event will also feature a pre-workshop tutorial session designed for those who are new to Japan pharmaceutical development and have limited understanding of Japan and its regulatory environment and drug approval process. The program is intended for research and development, regulatory affairs and clinical professionals in the United States and European Union who are currently involved in or considering liaisons with a subsidiary in Japan.
Participants attending this workshop will gain a greater understanding of the Japanese regulatory environment and will be able to recognize how regulatory requirements are influenced by medical practice and Japanese culture. They will also be able to identify recent changes within regulatory requirements, preclinical programs and clinical research environments, and become more familiar with the tools used to increase dialogue with the Japanese regulatory authority.
For more information on this program, contact Jolene.McNeil@diahome.org or download the brochure at http://www.diahome.org/Content/Events/05032.pdf.
Visit http://www.diahome.org/docs/events/events_search_detail.cfm?EventID=05032to register online.